Terminated OBSERVATIONAL NCT01550328

Bias Source of Signal in SCOUT DS (BSOS)

Sponsor: VeraLight, Inc.

Updated 7 times since 2017 Last updated: Jan 14, 2013 Started: Apr 30, 2012 Primary completion: Sep 30, 2012 Completion: Jan 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Protocol no longer meets sponsor objectives

Other Type 2 Diabetes trials with similar outcome

Browse all Type 2 Diabetes trials

This observational or N/A phase trial investigates Type 2 Diabetes and is currently terminated or withdrawn. VeraLight, Inc. leads this study, which shows 7 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated
Jul 2024 — Sep 2024 [monthly]

Terminated
Jan 2021 — Jul 2024 [monthly]

Terminated
Jun 2018 — Jan 2021 [monthly]

Terminated
Apr 2018 — Jun 2018 [monthly]

Terminated

Phase: NA → None

▶ Show 2 earlier versions

Feb 2017 — Apr 2018 [monthly]

Terminated NA
Jan 2017 — Feb 2017 [monthly]

Terminated NA

First recorded

Apr 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

VeraLight, Inc.

Data source: VeraLight, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Albuquerque, United States